Open sidebar
Focus
Bristol-Myers
Business & Markets
|
Reuters
Bristol Myers Boosts Cancer Drug Portfolio With $4.1 Billion Turning Point Deal
Jun 04, 2022
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Jun 04
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health News
|
Reuters
Bristol Myers Drug Wins First US Approval for Graft Versus Host Disease Prevention
Dec 15, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 15
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
